Aster DM Healthcare Limited has invested ₹25 crore to acquire 3,57,143 Optionally Convertible Redeemable Preference Shares (OCRPS) in its associate company, Alfaone Medicals Private Limited. The acquisition, completed on June 29, 2026, involved a subscription to a rights issue at a price of ₹700 per share, which includes a security premium of ₹690 per share. This strategic investment is intended for general corporate purposes within the healthcare sector.

The transaction was classified as a related party transaction since Alfaone Medicals is an associate of Aster DM Healthcare . The Board approved the deal, confirming it was conducted at arm’s length, with no interest held by the promoter or promoter group beyond the company’s existing stake. The consideration was paid in cash, and no specific governmental or regulatory approvals were required for the completion.

Alfaone Medicals Private Limited, incorporated on December 03, 2020, operates in the healthcare industry, specifically trading drugs and pharmaceuticals. The entity reported a turnover of ₹589.55 lakhs for the financial year ended March 31, 2026, compared to ₹616.32 lakhs in FY2024-25 and ₹621.79 lakhs in FY2023-24. The company is based in Bengaluru, Karnataka.

Following the allotment, Aster DM Healthcare’s holding in Alfaone Medicals consists of 11,50,941 equity shares, representing 48.91% of the equity share capital. The company now holds 37,54,243 OCRPS, which constitutes 100% of that class of shares. The total cost of acquisition was ₹25,00,00,100.

Financial Details of Acquisition

Alfaone Medicals Turnover History

Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, a subsidiary of aster dm healthcare , has allotted 46,30,000 Compulsorily Convertible Preference Shares (CCPS) to identified investors on a preferential basis by way of private placement. The allotment was approved by the subsidiary's board on June 23, 2026, pursuant to Regulation 30(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The issuance comprises both fully paid-up and partly paid-up shares, with a conversion ratio of up to 5 equity shares for each CCPS.

Breakdown of Allotment

The board allotted two distinct series of CCPS. Series A shares are fully paid-up, while Series B shares are partly paid-up. Both series carry a face value of Rs. 50 each.

Conversion and Shareholding Structure

The CCPS issued will convert into equity shares of the subsidiary. As on the date of allotment, the conversion ratio stipulates that each CCPS shall convert into a maximum of up to 5 equity shares. This conversion mechanism will dilute the shareholding of existing stakeholders, subject to the terms approved by the subsidiary's shareholders.

Aster DM Healthcare disclosed that its shareholding in the subsidiary will not go below 75% of the share capital on an as-if converted basis. This threshold accounts for the conversion of the allotted Series A CCPS, Series B CCPS, and any Additional Investment that the subsidiary may finalize in the future.

Future Capital Raising Plans

The subsidiary is actively pursuing further capital infusion. It is in the process of finalizing other investors to whom certain other CCPS may be issued in due course. This prospective issuance is referred to as Additional Investment. The company confirmed that the 75% minimum shareholding commitment for Aster DM Healthcare remains valid even after this Additional Investment is accounted for.

The filing was submitted by Hemish Purushottam, Company Secretary and Compliance Officer of Aster DM Healthcare Limited.